FDA greenlights 1st drug to delay onset of Type 1 diabetes

In a win for Red Bank, N.J.-based ProventionBio, the FDA approved its drug Tzield Nov. 17, marking the first approved therapy to delay the onset of Type 1 diabetes. 

Read the full post at Becker's Hospital Review - Healthcare News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive